Publications

BibTex format

@article{Aglago:2020:10.1158/1055-9965.EPI-20-0855,
author = {Aglago, EK and Rinaldi, S and Freisling, H and Jiao, L and Hughes, DJ and Fedirko, V and Schalkwijk, CG and Weiderpass, E and Dahm, CC and Overvad, K and Eriksen, AK and Kyrø, C and Boutron-Ruault, M-C and Rothwell, JA and Severi, G and Katzke, V and Kühn, T and Schulze, MB and Aleksandrova, K and Masala, G and Krogh, V and Panico, S and Tumino, R and Naccarati, A and Bueno-de-Mesquita, B and van, Gils CH and Sandanger, TM and Gram, IT and Skeie, G and Quirós, JR and Jakszyn, P and Sánchez, M-J and Amiano, P and Huerta, JM and Ardanaz, E and Johansson, I and Harlid, S and Perez-Cornago, A and Mayén, A-L and Cordova, R and Gunter, MJ and Vineis, P and Cross, AJ and Riboli, E and Jenab, M},
doi = {10.1158/1055-9965.EPI-20-0855},
journal = {Cancer Epidemiology, Biomarkers and Prevention},
title = {Soluble Receptor for Advanced Glycation End-products (sRAGE) and Colorectal Cancer Risk: A Case-Control Study Nested within a European Prospective Cohort},
url = {http://dx.doi.org/10.1158/1055-9965.EPI-20-0855},
volume = {30},
year = {2020}
}

Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - BACKGROUND: Overexpression of the receptor for advanced glycation end-product (RAGE) has been associated with chronic inflammation, which in turn has been associated with increased colorectal cancer risk. Soluble RAGE (sRAGE) competes with RAGE to bind its ligands, thus potentially preventing RAGE-induced inflammation. METHODS: To investigate whether sRAGE and related genetic variants are associated with colorectal cancer risk, we conducted a nested case-control study in the European Prospective Investigation into Cancer and Nutrition (EPIC). Plasma sRAGE concentrations were measured by ELISA in 1,361 colorectal cancer matched case-control sets. Twenty-four SNPs encoded in the genes associated with sRAGE concentrations were available for 1,985 colorectal cancer cases and 2,220 controls. Multivariable adjusted ORs and 95% confidence intervals (CIs) were computed using conditional and unconditional logistic regression for colorectal cancer risk and circulating sRAGE and SNPs, respectively. RESULTS: Higher sRAGE concentrations were inversely associated with colorectal cancer (ORQ5vs.Q1, 0.77; 95% CI, 0.59-1.00). Sex-specific analyses revealed that the observed inverse risk association was restricted to men (ORQ5vs.Q1, 0.63; 95% CI, 0.42-0.94), whereas no association was observed in women (ORQ5vs.Q1, 1.00; 95% CI, 0.68-1.48; Pheterogeneity for sex = 0.006). Participants carrying minor allele of rs653765 (promoter region of ADAM10) had lower colorectal cancer risk (C vs. T, OR, 0.90; 95% CI, 0.82-0.99). CONCLUSIONS: Prediagnostic sRAGE concentrations were inversely associated with colorectal cancer risk in men, but not in women. An SNP located within ADAM10 gene, pertaining to RAGE shedding, was associated with colorectal cancer risk. IMPACT: Further studies are needed to confirm our observed sex difference in the association and better explore the potential involvement of genetic variants of sRAGE in colorectal cancer development.
AU  - Aglago,EK
AU  - Rinaldi,S
AU  - Freisling,H
AU  - Jiao,L
AU  - Hughes,DJ
AU  - Fedirko,V
AU  - Schalkwijk,CG
AU  - Weiderpass,E
AU  - Dahm,CC
AU  - Overvad,K
AU  - Eriksen,AK
AU  - Kyrø,C
AU  - Boutron-Ruault,M-C
AU  - Rothwell,JA
AU  - Severi,G
AU  - Katzke,V
AU  - Kühn,T
AU  - Schulze,MB
AU  - Aleksandrova,K
AU  - Masala,G
AU  - Krogh,V
AU  - Panico,S
AU  - Tumino,R
AU  - Naccarati,A
AU  - Bueno-de-Mesquita,B
AU  - van,Gils CH
AU  - Sandanger,TM
AU  - Gram,IT
AU  - Skeie,G
AU  - Quirós,JR
AU  - Jakszyn,P
AU  - Sánchez,M-J
AU  - Amiano,P
AU  - Huerta,JM
AU  - Ardanaz,E
AU  - Johansson,I
AU  - Harlid,S
AU  - Perez-Cornago,A
AU  - Mayén,A-L
AU  - Cordova,R
AU  - Gunter,MJ
AU  - Vineis,P
AU  - Cross,AJ
AU  - Riboli,E
AU  - Jenab,M
DO  - 10.1158/1055-9965.EPI-20-0855
PY  - 2020///
SN  - 1055-9965
TI  - Soluble Receptor for Advanced Glycation End-products (sRAGE) and Colorectal Cancer Risk: A Case-Control Study Nested within a European Prospective Cohort
T2  - Cancer Epidemiology, Biomarkers and Prevention
UR  - http://dx.doi.org/10.1158/1055-9965.EPI-20-0855
UR  - https://www.ncbi.nlm.nih.gov/pubmed/33082206
UR  - https://cebp.aacrjournals.org/content/30/1/182
UR  - http://hdl.handle.net/10044/1/85564
VL  - 30
ER  -

Download

Professor Amanda Cross

Contact

Assistant

Location

Summary

Citation

BibTex format

RIS format (EndNote, RefMan)